Recent progress in targeted therapy for non-small cell lung cancer

The high morbidity and mortality of non-small cell lung cancer (NSCLC) have always been major threats to people’s health. With the identification of carcinogenic drivers in non-small cell lung cancer and the clinical application of targeted drugs, the prognosis of non-small cell lung cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yanxia, Liu, Pu, Wei, Jie, Zhang, Xin, Guo, Jun, Lin, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994183/
https://www.ncbi.nlm.nih.gov/pubmed/36909198
http://dx.doi.org/10.3389/fphar.2023.1125547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994183/
https://www.ncbi.nlm.nih.gov/pubmed/36909198
http://dx.doi.org/10.3389/fphar.2023.1125547

Ejemplares similares